CHUM, Hopital St-Luc

Montreal, Quebec H2X 3J4

0 studies enrolling now · 4 studies all time

What they study most

Angioplasty, Transluminal, Percutaneous Coronary, Benign Prostatic Hypertrophy, Hepatocellular Carcinoma, Hepatorenal Syndrome

Studies at this site

• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed